APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oral Polio Vaccines (OPV)

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Oral Polio Vaccines (OPV) Industry Growth and Trends Forecast to 2032

20 December 202597 pages

Choose your research edition.

Industry ResearchOral Polio Vaccines (OPV) Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Oral Polio Vaccines (OPV) Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Oral Polio Vaccines (OPV) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oral Polio Vaccines (OPV) Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Oral Polio Vaccines (OPV) Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Oral Polio Vaccines (OPV) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Oral Polio Vaccines (OPV) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Oral Polio Vaccines (OPV) is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Oral Polio Vaccines (OPV) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Oral Polio Vaccines (OPV) include Sanofi, GSK, Tiantan Biological, Serum Institute, Panacea Biotec Ltd, IMBCA, Halfkin Bio-Pharmaceuticals, Bio-Med and Bibcol, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Oral Polio Vaccines (OPV) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Oral Polio Vaccines (OPV) market size, estimates, and forecasts are presented in terms of sales volume (k doses) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Oral Polio Vaccines (OPV) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Oral Polio Vaccines (OPV).

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Oral Polio Vaccines (OPV) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Oral Polio Vaccines (OPV) Market by Company

Sanofi

GSK

Tiantan Biological

Serum Institute

Panacea Biotec Ltd

IMBCA

Halfkin Bio-Pharmaceuticals

Bio-Med

Bibcol

Oral Polio Vaccines (OPV) Segment by Type

Trivalent OPV

Bivalent OPV

Oral Polio Vaccines (OPV) Segment by Application

Public

Private

Oral Polio Vaccines (OPV) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Polio Vaccines (OPV) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oral Polio Vaccines (OPV) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Polio Vaccines (OPV).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Oral Polio Vaccines (OPV) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Oral Polio Vaccines (OPV) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Trivalent OPV Table 2. Major Company of Bivalent OPV Table 3. Global Oral Polio Vaccines (OPV) Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Oral Polio Vaccines (OPV) Sales by Type (2021-2026) & (k doses) Table 5. Global Oral Polio Vaccines (OPV) Sales Market Share in Volume by Type (2021-2026) Table 6. Global Oral Polio Vaccines (OPV) Sales by Type (2021-2026) & (US$ Million) Table 7. Global Oral Polio Vaccines (OPV) Sales Market Share in Value by Type (2021-2026) Table 8. Global Oral Polio Vaccines (OPV) Price by Type (2021-2026) & (US$/dose) Table 9. Global Oral Polio Vaccines (OPV) Sales by Type (2027-2032) & (k doses) Table 10. Global Oral Polio Vaccines (OPV) Sales Market Share in Volume by Type (2027-2032) Table 11. Global Oral Polio Vaccines (OPV) Sales by Type (2027-2032) & (US$ Million) Table 12. Global Oral Polio Vaccines (OPV) Sales Market Share in Value by Type (2027-2032) Table 13. Global Oral Polio Vaccines (OPV) Price by Type (2027-2032) & (US$/dose) Table 14. North America Oral Polio Vaccines (OPV) Sales by Type (2021-2026) & (k doses) Table 15. North America Oral Polio Vaccines (OPV) Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Oral Polio Vaccines (OPV) Sales by Type (2021-2026) & (k doses) Table 17. Europe Oral Polio Vaccines (OPV) Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Oral Polio Vaccines (OPV) Sales by Type (2021-2026) & (k doses) Table 19. Asia-Pacific Oral Polio Vaccines (OPV) Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Oral Polio Vaccines (OPV) Sales by Type (2021-2026) & (k doses) Table 21. Latin America Oral Polio Vaccines (OPV) Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Oral Polio Vaccines (OPV) Sales by Type (2021-2026) & (k doses) Table 23. Middle East and Africa Oral Polio Vaccines (OPV) Sales by Type (2021-2026) & (US$ Million) Table 24. Oral Polio Vaccines (OPV) Industry Trends Table 25. Oral Polio Vaccines (OPV) Industry Drivers Table 26. Oral Polio Vaccines (OPV) Industry Opportunities and Challenges Table 27. Oral Polio Vaccines (OPV) Industry Restraints Table 28. Global Oral Polio Vaccines (OPV) Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Oral Polio Vaccines (OPV) Revenue Market Share by Company (2021-2026) Table 30. Global Oral Polio Vaccines (OPV) Sales by Company (2021-2026) & (k doses) Table 31. Global Oral Polio Vaccines (OPV) Sales Share by Company (2021-2026) Table 32. Global Oral Polio Vaccines (OPV) Market Price by Company (2021-2026) & (US$/dose) Table 33. Global Oral Polio Vaccines (OPV) Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Oral Polio Vaccines (OPV) Major Company Production Sites and Headquarters Table 35. Global Oral Polio Vaccines (OPV) Company, Product Type & Application Table 36. Global Oral Polio Vaccines (OPV) Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Oral Polio Vaccines (OPV) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Oral Polio Vaccines (OPV) Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Oral Polio Vaccines (OPV) Sales by Region (2021-2026) & (k doses) Table 41. Global Oral Polio Vaccines (OPV) Sales Market Share in Volume by Region (2021-2026) Table 42. Global Oral Polio Vaccines (OPV) Sales by Region (2021-2026) & (US$ Million) Table 43. Global Oral Polio Vaccines (OPV) Sales Market Share in Value by Region (2021-2026) Table 44. Global Oral Polio Vaccines (OPV) Sales (k doses), Value (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 45. Global Oral Polio Vaccines (OPV) Sales by Region (2027-2032) & (k doses) Table 46. Global Oral Polio Vaccines (OPV) Sales Market Share in Volume by Region (2027-2032) Table 47. Global Oral Polio Vaccines (OPV) Sales by Region (2027-2032) & (US$ Million) Table 48. Global Oral Polio Vaccines (OPV) Sales Market Share in Value by Region (2027-2032) Table 49. Global Oral Polio Vaccines (OPV) Sales (k doses), Value (US$ Million), Price (US$/dose) and Gross Margin (2027-2032) Table 50. Global Oral Polio Vaccines (OPV) Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Oral Polio Vaccines (OPV) Sales by Application (2021-2026) & (k doses) Table 52. Global Oral Polio Vaccines (OPV) Sales Market Share in Volume by Application (2021-2026) Table 53. Global Oral Polio Vaccines (OPV) Sales by Application (2021-2026) & (US$ Million) Table 54. Global Oral Polio Vaccines (OPV) Sales Market Share in Value by Application (2021-2026) Table 55. Global Oral Polio Vaccines (OPV) Price by Application (2021-2026) & (US$/dose) Table 56. Global Oral Polio Vaccines (OPV) Sales by Application (2027-2032) & (k doses) Table 57. Global Oral Polio Vaccines (OPV) Sales Market Share in Volume by Application (2027-2032) Table 58. Global Oral Polio Vaccines (OPV) Sales by Application (2027-2032) & (US$ Million) Table 59. Global Oral Polio Vaccines (OPV) Sales Market Share in Value by Application (2027-2032) Table 60. Global Oral Polio Vaccines (OPV) Price by Application (2027-2032) & (US$/dose) Table 61. North America Oral Polio Vaccines (OPV) Sales by Application (2021-2026) & (k doses) Table 62. North America Oral Polio Vaccines (OPV) Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Oral Polio Vaccines (OPV) Sales by Application (2021-2026) & (k doses) Table 64. Europe Oral Polio Vaccines (OPV) Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Oral Polio Vaccines (OPV) Sales by Application (2021-2026) & (k doses) Table 66. Asia-Pacific Oral Polio Vaccines (OPV) Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Oral Polio Vaccines (OPV) Sales by Application (2021-2026) & (k doses) Table 68. Latin America Oral Polio Vaccines (OPV) Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Oral Polio Vaccines (OPV) Sales by Application (2021-2026) & (k doses) Table 70. Middle East and Africa Oral Polio Vaccines (OPV) Sales by Application (2021-2026) & (US$ Million) Table 71. Sanofi Company Information Table 72. Sanofi Business Overview Table 73. Sanofi Oral Polio Vaccines (OPV) Sales (k doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 74. Sanofi Oral Polio Vaccines (OPV) Product Portfolio Table 75. Sanofi Recent Development Table 76. GSK Company Information Table 77. GSK Business Overview Table 78. GSK Oral Polio Vaccines (OPV) Sales (k doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 79. GSK Oral Polio Vaccines (OPV) Product Portfolio Table 80. GSK Recent Development Table 81. Tiantan Biological Company Information Table 82. Tiantan Biological Business Overview Table 83. Tiantan Biological Oral Polio Vaccines (OPV) Sales (k doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 84. Tiantan Biological Oral Polio Vaccines (OPV) Product Portfolio Table 85. Tiantan Biological Recent Development Table 86. Serum Institute Company Information Table 87. Serum Institute Business Overview Table 88. Serum Institute Oral Polio Vaccines (OPV) Sales (k doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 89. Serum Institute Oral Polio Vaccines (OPV) Product Portfolio Table 90. Serum Institute Recent Development Table 91. Panacea Biotec Ltd Company Information Table 92. Panacea Biotec Ltd Business Overview Table 93. Panacea Biotec Ltd Oral Polio Vaccines (OPV) Sales (k doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 94. Panacea Biotec Ltd Oral Polio Vaccines (OPV) Product Portfolio Table 95. Panacea Biotec Ltd Recent Development Table 96. IMBCA Company Information Table 97. IMBCA Business Overview Table 98. IMBCA Oral Polio Vaccines (OPV) Sales (k doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 99. IMBCA Oral Polio Vaccines (OPV) Product Portfolio Table 100. IMBCA Recent Development Table 101. Halfkin Bio-Pharmaceuticals Company Information Table 102. Halfkin Bio-Pharmaceuticals Business Overview Table 103. Halfkin Bio-Pharmaceuticals Oral Polio Vaccines (OPV) Sales (k doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 104. Halfkin Bio-Pharmaceuticals Oral Polio Vaccines (OPV) Product Portfolio Table 105. Halfkin Bio-Pharmaceuticals Recent Development Table 106. Bio-Med Company Information Table 107. Bio-Med Business Overview Table 108. Bio-Med Oral Polio Vaccines (OPV) Sales (k doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 109. Bio-Med Oral Polio Vaccines (OPV) Product Portfolio Table 110. Bio-Med Recent Development Table 111. Bibcol Company Information Table 112. Bibcol Business Overview Table 113. Bibcol Oral Polio Vaccines (OPV) Sales (k doses), Revenue (US$ Million), Price (US$/dose) and Gross Margin (2021-2026) Table 114. Bibcol Oral Polio Vaccines (OPV) Product Portfolio Table 115. Bibcol Recent Development Table 116. North America Oral Polio Vaccines (OPV) Market Size Growth Rate (CAGR) by Country (k doses): 2021 VS 2025 VS 2032 Table 117. North America Oral Polio Vaccines (OPV) Sales by Country (2021-2026) & (k doses) Table 118. North America Oral Polio Vaccines (OPV) Sales Market Share by Country (2021-2026) Table 119. North America Oral Polio Vaccines (OPV) Sales Forecast by Country (2027-2032) & (k doses) Table 120. North America Oral Polio Vaccines (OPV) Sales Market Share Forecast by Country (2027-2032) Table 121. North America Oral Polio Vaccines (OPV) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. North America Oral Polio Vaccines (OPV) Market Size by Country (2021-2026) & (US$ Million) Table 123. North America Oral Polio Vaccines (OPV) Market Share by Country (2021-2026) Table 124. North America Oral Polio Vaccines (OPV) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. North America Oral Polio Vaccines (OPV) Market Share Forecast by Country (2027-2032) Table 126. Europe Oral Polio Vaccines (OPV) Market Size Growth Rate (CAGR) by Country (k doses): 2021 VS 2025 VS 2032 Table 127. Europe Oral Polio Vaccines (OPV) Sales by Country (2021-2026) & (k doses) Table 128. Europe Oral Polio Vaccines (OPV) Sales Market Share by Country (2021-2026) Table 129. Europe Oral Polio Vaccines (OPV) Sales Forecast by Country (2027-2032) & (k doses) Table 130. Europe Oral Polio Vaccines (OPV) Sales Market Share Forecast by Country (2027-2032) Table 131. Europe Oral Polio Vaccines (OPV) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Europe Oral Polio Vaccines (OPV) Market Size by Country (2021-2026) & (US$ Million) Table 133. Europe Oral Polio Vaccines (OPV) Market Share by Country (2021-2026) Table 134. Europe Oral Polio Vaccines (OPV) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Europe Oral Polio Vaccines (OPV) Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Oral Polio Vaccines (OPV) Market Size Growth Rate (CAGR) by Country (k doses): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Oral Polio Vaccines (OPV) Sales by Country (2021-2026) & (k doses) Table 138. Asia-Pacific Oral Polio Vaccines (OPV) Sales Market Share by Country (2021-2026) Table 139. Asia-Pacific Oral Polio Vaccines (OPV) Sales Forecast by Country (2027-2032) & (k doses) Table 140. Asia-Pacific Oral Polio Vaccines (OPV) Sales Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Oral Polio Vaccines (OPV) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Oral Polio Vaccines (OPV) Market Size by Country (2021-2026) & (US$ Million) Table 143. Asia-Pacific Oral Polio Vaccines (OPV) Market Share by Country (2021-2026) Table 144. Asia-Pacific Oral Polio Vaccines (OPV) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Asia-Pacific Oral Polio Vaccines (OPV) Market Share Forecast by Country (2027-2032) Table 146. Latin America Oral Polio Vaccines (OPV) Market Size Growth Rate (CAGR) by Country (k doses): 2021 VS 2025 VS 2032 Table 147. Latin America Oral Polio Vaccines (OPV) Sales by Country (2021-2026) & (k doses) Table 148. Latin America Oral Polio Vaccines (OPV) Sales Market Share by Country (2021-2026) Table 149. Latin America Oral Polio Vaccines (OPV) Sales Forecast by Country (2027-2032) & (k doses) Table 150. Latin America Oral Polio Vaccines (OPV) Sales Market Share Forecast by Country (2027-2032) Table 151. Latin America Oral Polio Vaccines (OPV) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Latin America Oral Polio Vaccines (OPV) Market Size by Country (2021-2026) & (US$ Million) Table 153. Latin America Oral Polio Vaccines (OPV) Market Share by Country (2021-2026) Table 154. Latin America Oral Polio Vaccines (OPV) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Latin America Oral Polio Vaccines (OPV) Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Oral Polio Vaccines (OPV) Market Size Growth Rate (CAGR) by Country (k doses): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Oral Polio Vaccines (OPV) Sales by Country (2021-2026) & (k doses) Table 158. Middle East and Africa Oral Polio Vaccines (OPV) Sales Market Share by Country (2021-2026) Table 159. Middle East and Africa Oral Polio Vaccines (OPV) Sales Forecast by Country (2027-2032) & (k doses) Table 160. Middle East and Africa Oral Polio Vaccines (OPV) Sales Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Oral Polio Vaccines (OPV) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Oral Polio Vaccines (OPV) Market Size by Country (2021-2026) & (US$ Million) Table 163. Middle East and Africa Oral Polio Vaccines (OPV) Market Share by Country (2021-2026) Table 164. Middle East and Africa Oral Polio Vaccines (OPV) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Middle East and Africa Oral Polio Vaccines (OPV) Market Share Forecast by Country (2027-2032) Table 166. Key Raw Materials Table 167. Raw Materials Key Suppliers Table 168. Oral Polio Vaccines (OPV) Distributors List Table 169. Oral Polio Vaccines (OPV) Customers List Table 170. Research Programs/Design for This Report Table 171. Authors List of This Report Table 172. Secondary Sources Table 173. Primary Sources List of Figures Figure 1. Oral Polio Vaccines (OPV) Image Figure 2. Global Oral Polio Vaccines (OPV) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oral Polio Vaccines (OPV) Market Size (2021-2032) & (US$ Million) Figure 4. Global Oral Polio Vaccines (OPV) Sales (2021-2032) & (k doses) Figure 5. Trivalent OPV Image Figure 6. Global Trivalent OPV Sales YoY Growth (2021-2032) & (k doses) Figure 7. Bivalent OPV Image Figure 8. Global Bivalent OPV Sales YoY Growth (2021-2032) & (k doses) Figure 9. Global Oral Polio Vaccines (OPV) Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Oral Polio Vaccines (OPV) Market Share by Type 2025 VS 2032 Figure 11. North America Oral Polio Vaccines (OPV) Sales Market Share in Volume by Type in 2025 Figure 12. North America Oral Polio Vaccines (OPV) Sales Market Share in Value by Type in 2025 Figure 13. Europe Oral Polio Vaccines (OPV) Sales Market Share in Volume by Type in 2025 Figure 14. Europe Oral Polio Vaccines (OPV) Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Oral Polio Vaccines (OPV) Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Oral Polio Vaccines (OPV) Sales Market Share in Value by Type in 2025 Figure 17. Latin America Oral Polio Vaccines (OPV) Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Oral Polio Vaccines (OPV) Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Oral Polio Vaccines (OPV) Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Oral Polio Vaccines (OPV) Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Oral Polio Vaccines (OPV) Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Public Image Figure 24. Global Public Sales YoY Growth (2021-2032) & (k doses) Figure 25. Private Image Figure 26. Global Private Sales YoY Growth (2021-2032) & (k doses) Figure 27. Global Oral Polio Vaccines (OPV) Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Oral Polio Vaccines (OPV) Market Share by Application 2025 VS 2032 Figure 29. North America Oral Polio Vaccines (OPV) Sales Market Share in Volume by Application in 2025 Figure 30. North America Oral Polio Vaccines (OPV) Sales Market Share in Value by Application in 2025 Figure 31. Europe Oral Polio Vaccines (OPV) Sales Market Share in Volume by Application in 2025 Figure 32. Europe Oral Polio Vaccines (OPV) Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Oral Polio Vaccines (OPV) Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Oral Polio Vaccines (OPV) Sales Market Share in Value by Application in 2025 Figure 35. Latin America Oral Polio Vaccines (OPV) Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Oral Polio Vaccines (OPV) Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Oral Polio Vaccines (OPV) Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Oral Polio Vaccines (OPV) Sales Market Share in Value by Application in 2025 Figure 39. North America Oral Polio Vaccines (OPV) Sales by Country: 2021 VS 2025 VS 2032 (k doses) Figure 40. North America Oral Polio Vaccines (OPV) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Oral Polio Vaccines (OPV) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Oral Polio Vaccines (OPV) Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Oral Polio Vaccines (OPV) Sales by Country: 2021 VS 2025 VS 2032 (k doses) Figure 44. Europe Oral Polio Vaccines (OPV) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Oral Polio Vaccines (OPV) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Oral Polio Vaccines (OPV) Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Oral Polio Vaccines (OPV) Sales by Country: 2021 VS 2025 VS 2032 (k doses) Figure 48. Asia-Pacific Oral Polio Vaccines (OPV) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Oral Polio Vaccines (OPV) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Oral Polio Vaccines (OPV) Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Oral Polio Vaccines (OPV) Sales by Country: 2021 VS 2025 VS 2032 (k doses) Figure 52. Latin America Oral Polio Vaccines (OPV) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Oral Polio Vaccines (OPV) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Oral Polio Vaccines (OPV) Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Oral Polio Vaccines (OPV) Sales by Country: 2021 VS 2025 VS 2032 (k doses) Figure 56. Middle East and Africa Oral Polio Vaccines (OPV) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Oral Polio Vaccines (OPV) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Oral Polio Vaccines (OPV) Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Oral Polio Vaccines (OPV) Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Oral Polio Vaccines (OPV) Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Trivalent OPV
  • Bivalent OPV
Applications
  • Public
  • Private
Companies covered
  • Sanofi
  • GSK
  • Tiantan Biological
  • Serum Institute
  • Panacea Biotec Ltd
  • IMBCA
  • Halfkin Bio-Pharmaceuticals
  • Bio-Med
  • Bibcol

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Oral Polio Vaccines (OPV) Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Oral Polio Vaccines (OPV) Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Oral Polio Vaccines (OPV) Market by Type
  6. 1.3.1 Trivalent OPV
  7. 1.3.2 Bivalent OPV
  8. 1.4 Global Oral Polio Vaccines (OPV) Market Size by Type
  9. 1.4.1 Global Oral Polio Vaccines (OPV) Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Oral Polio Vaccines (OPV) Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Oral Polio Vaccines (OPV) Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Oral Polio Vaccines (OPV) Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Oral Polio Vaccines (OPV) Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Oral Polio Vaccines (OPV) Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Oral Polio Vaccines (OPV) Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Oral Polio Vaccines (OPV) Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Oral Polio Vaccines (OPV) Industry Trends
  2. 2.2 Oral Polio Vaccines (OPV) Industry Drivers
  3. 2.3 Oral Polio Vaccines (OPV) Industry Opportunities and Challenges
  4. 2.4 Oral Polio Vaccines (OPV) Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Oral Polio Vaccines (OPV) Revenue (2021-2026)
  2. 3.2 Global Top Players by Oral Polio Vaccines (OPV) Sales (2021-2026)
  3. 3.3 Global Top Players by Oral Polio Vaccines (OPV) Price (2021-2026)
  4. 3.4 Global Oral Polio Vaccines (OPV) Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Oral Polio Vaccines (OPV) Major Company Production Sites & Headquarters
  6. 3.6 Global Oral Polio Vaccines (OPV) Company, Product Type & Application
  7. 3.7 Global Oral Polio Vaccines (OPV) Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Oral Polio Vaccines (OPV) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Oral Polio Vaccines (OPV) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Oral Polio Vaccines (OPV) Tier 1, Tier 2, and Tier 3
4 Oral Polio Vaccines (OPV) Regional Status and Outlook
  1. 4.1 Global Oral Polio Vaccines (OPV) Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Oral Polio Vaccines (OPV) Historic Market Size by Region
  3. 4.2.1 Global Oral Polio Vaccines (OPV) Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Oral Polio Vaccines (OPV) Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Oral Polio Vaccines (OPV) Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Oral Polio Vaccines (OPV) Forecasted Market Size by Region
  7. 4.3.1 Global Oral Polio Vaccines (OPV) Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Oral Polio Vaccines (OPV) Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Oral Polio Vaccines (OPV) Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Oral Polio Vaccines (OPV) by Application
  1. 5.1 Oral Polio Vaccines (OPV) Market by Application
  2. 5.1.1 Public
  3. 5.1.2 Private
  4. 5.2 Global Oral Polio Vaccines (OPV) Market Size by Application
  5. 5.2.1 Global Oral Polio Vaccines (OPV) Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Oral Polio Vaccines (OPV) Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Oral Polio Vaccines (OPV) Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Oral Polio Vaccines (OPV) Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Oral Polio Vaccines (OPV) Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Oral Polio Vaccines (OPV) Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Oral Polio Vaccines (OPV) Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Oral Polio Vaccines (OPV) Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sanofi
  2. 6.1.1 Sanofi Company Information
  3. 6.1.2 Sanofi Business Overview
  4. 6.1.3 Sanofi Oral Polio Vaccines (OPV) Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sanofi Oral Polio Vaccines (OPV) Product Portfolio
  6. 6.1.5 Sanofi Recent Developments
  7. 6.2 GSK
  8. 6.2.1 GSK Company Information
  9. 6.2.2 GSK Business Overview
  10. 6.2.3 GSK Oral Polio Vaccines (OPV) Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 GSK Oral Polio Vaccines (OPV) Product Portfolio
  12. 6.2.5 GSK Recent Developments
  13. 6.3 Tiantan Biological
  14. 6.3.1 Tiantan Biological Company Information
  15. 6.3.2 Tiantan Biological Business Overview
  16. 6.3.3 Tiantan Biological Oral Polio Vaccines (OPV) Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Tiantan Biological Oral Polio Vaccines (OPV) Product Portfolio
  18. 6.3.5 Tiantan Biological Recent Developments
  19. 6.4 Serum Institute
  20. 6.4.1 Serum Institute Company Information
  21. 6.4.2 Serum Institute Business Overview
  22. 6.4.3 Serum Institute Oral Polio Vaccines (OPV) Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Serum Institute Oral Polio Vaccines (OPV) Product Portfolio
  24. 6.4.5 Serum Institute Recent Developments
  25. 6.5 Panacea Biotec Ltd
  26. 6.5.1 Panacea Biotec Ltd Company Information
  27. 6.5.2 Panacea Biotec Ltd Business Overview
  28. 6.5.3 Panacea Biotec Ltd Oral Polio Vaccines (OPV) Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Panacea Biotec Ltd Oral Polio Vaccines (OPV) Product Portfolio
  30. 6.5.5 Panacea Biotec Ltd Recent Developments
  31. 6.6 IMBCA
  32. 6.6.1 IMBCA Company Information
  33. 6.6.2 IMBCA Business Overview
  34. 6.6.3 IMBCA Oral Polio Vaccines (OPV) Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 IMBCA Oral Polio Vaccines (OPV) Product Portfolio
  36. 6.6.5 IMBCA Recent Developments
  37. 6.7 Halfkin Bio-Pharmaceuticals
  38. 6.7.1 Halfkin Bio-Pharmaceuticals Company Information
  39. 6.7.2 Halfkin Bio-Pharmaceuticals Business Overview
  40. 6.7.3 Halfkin Bio-Pharmaceuticals Oral Polio Vaccines (OPV) Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Halfkin Bio-Pharmaceuticals Oral Polio Vaccines (OPV) Product Portfolio
  42. 6.7.5 Halfkin Bio-Pharmaceuticals Recent Developments
  43. 6.8 Bio-Med
  44. 6.8.1 Bio-Med Company Information
  45. 6.8.2 Bio-Med Business Overview
  46. 6.8.3 Bio-Med Oral Polio Vaccines (OPV) Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Bio-Med Oral Polio Vaccines (OPV) Product Portfolio
  48. 6.8.5 Bio-Med Recent Developments
  49. 6.9 Bibcol
  50. 6.9.1 Bibcol Company Information
  51. 6.9.2 Bibcol Business Overview
  52. 6.9.3 Bibcol Oral Polio Vaccines (OPV) Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Bibcol Oral Polio Vaccines (OPV) Product Portfolio
  54. 6.9.5 Bibcol Recent Developments
7 North America by Country
  1. 7.1 North America Oral Polio Vaccines (OPV) Sales by Country
  2. 7.1.1 North America Oral Polio Vaccines (OPV) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Oral Polio Vaccines (OPV) Sales by Country (2021-2026)
  4. 7.1.3 North America Oral Polio Vaccines (OPV) Sales Forecast by Country (2027-2032)
  5. 7.2 North America Oral Polio Vaccines (OPV) Market Size by Country
  6. 7.2.1 North America Oral Polio Vaccines (OPV) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Oral Polio Vaccines (OPV) Market Size by Country (2021-2026)
  8. 7.2.3 North America Oral Polio Vaccines (OPV) Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Oral Polio Vaccines (OPV) Sales by Country
  2. 8.1.1 Europe Oral Polio Vaccines (OPV) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Oral Polio Vaccines (OPV) Sales by Country (2021-2026)
  4. 8.1.3 Europe Oral Polio Vaccines (OPV) Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Oral Polio Vaccines (OPV) Market Size by Country
  6. 8.2.1 Europe Oral Polio Vaccines (OPV) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Oral Polio Vaccines (OPV) Market Size by Country (2021-2026)
  8. 8.2.3 Europe Oral Polio Vaccines (OPV) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Oral Polio Vaccines (OPV) Sales by Country
  2. 9.1.1 Asia-Pacific Oral Polio Vaccines (OPV) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Oral Polio Vaccines (OPV) Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Oral Polio Vaccines (OPV) Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Oral Polio Vaccines (OPV) Market Size by Country
  6. 9.2.1 Asia-Pacific Oral Polio Vaccines (OPV) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Oral Polio Vaccines (OPV) Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Oral Polio Vaccines (OPV) Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Oral Polio Vaccines (OPV) Sales by Country
  2. 10.1.1 South America Oral Polio Vaccines (OPV) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Oral Polio Vaccines (OPV) Sales by Country (2021-2026)
  4. 10.1.3 South America Oral Polio Vaccines (OPV) Sales Forecast by Country (2027-2032)
  5. 10.2 South America Oral Polio Vaccines (OPV) Market Size by Country
  6. 10.2.1 South America Oral Polio Vaccines (OPV) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Oral Polio Vaccines (OPV) Market Size by Country (2021-2026)
  8. 10.2.3 South America Oral Polio Vaccines (OPV) Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Oral Polio Vaccines (OPV) Sales by Country
  2. 11.1.1 Middle East and Africa Oral Polio Vaccines (OPV) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Oral Polio Vaccines (OPV) Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Oral Polio Vaccines (OPV) Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Oral Polio Vaccines (OPV) Market Size by Country
  6. 11.2.1 Middle East and Africa Oral Polio Vaccines (OPV) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Oral Polio Vaccines (OPV) Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Oral Polio Vaccines (OPV) Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Oral Polio Vaccines (OPV) Value Chain Analysis
  2. 12.1.1 Oral Polio Vaccines (OPV) Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Oral Polio Vaccines (OPV) Production Mode & Process
  7. 12.2 Oral Polio Vaccines (OPV) Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Oral Polio Vaccines (OPV) Distributors
  10. 12.2.3 Oral Polio Vaccines (OPV) Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst